B. Metzler seel. Sohn & Co’s AtriCure ATRC Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Hold	49,876	–	–	0.01%	505
2026 Q1	$1.42M	Hold	49,876	–	–	0.01%	465
2025 Q4	$1.97M	Hold	49,876	–	–	0.02%	409
2025 Q3	$1.76M	Hold	49,876	–	–	0.02%	420
2025 Q2	$1.63M	Buy	49,876 +18,510	+59%	+$602K	0.02%	424
2025 Q1	$1.01M	Hold	31,366	–	–	0.01%	519
2024 Q4	$959K	Hold	31,366	–	–	0.01%	547
2024 Q3	$880K	Hold	31,366	–	–	0.01%	569
2024 Q2	$714K	Hold	31,366	–	–	0.01%	586
2024 Q1	$954K	Hold	31,366	–	–	0.01%	528
2023 Q4	$1.12M	Buy	31,366 +3,319	+12%	+$123K	0.01%	484
2023 Q3	$1.23M	Sell	28,047 -24,427	-47%	-$1.19M	0.02%	423
2023 Q2	$2.59M	Buy	52,474 +27,914	+114%	+$1.29M	0.04%	315
2023 Q1	$1.02M	Buy	24,560 +1,902	+8%	+$78.9K	0.02%	438
2022 Q4	$1.01M	Hold	22,658	–	–	0.02%	428
2022 Q3	$886K	Buy	22,658 +687	+3%	+$31.4K	0.02%	443
2022 Q2	$898K	Hold	21,971	–	–	0.01%	460
2022 Q1	$1.44M	Buy	+21,971	New	+$1.42M	0.02%	405

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

B. Metzler seel. Sohn & Co's ATRC Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co held its AtriCure (ATRC) position steady in Q2 2026 at 49,876 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #505.

B. Metzler seel. Sohn & Co first reported a position in ATRC in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.59M in Q2 2023. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

B. Metzler seel. Sohn & Co held 49,876 shares of AtriCure worth $1.4M as of Q2 2026.
B. Metzler seel. Sohn & Co left its AtriCure share count unchanged in Q2 2026.
AtriCure made up 0.01% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #505 holding.
B. Metzler seel. Sohn & Co first reported a position in AtriCure in Q1 2022 and has held it in 18 quarters since.
B. Metzler seel. Sohn & Co's AtriCure position peaked at $2.59M in Q2 2023.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.